Prostate cancer risk among users of finasteride and alpha-blockers – A population based case–control study
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference25 articles.
1. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0;Ferlay,2004
2. Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia;Fong;Curr Opin Urol,2005
3. Human prostate cancer risk factors;Bostwick;Cancer,2004
4. Evidence-based meta-analysis of pharmacotherapy for benign prostatic hypertrophy;Ishizuka;Int J Urol,2002
5. The influence of finasteride on the development of prostate cancer;Thompson;N Engl J Med,2003
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists;JNCI: Journal of the National Cancer Institute;2024-05-08
2. Five-alpha reductase inhibitors and risk of prostate cancer among men with benign prostatic hyperplasia: A historical cohort study using primary care data;Wellcome Open Research;2023-07-11
3. Prostate Cancer Risk and Prognostic Influence Among Users of 5-Alpha-Reductase Inhibitors and Alpha-Blockers: A Systematic Review and Meta-Analysis;Urology;2020-11
4. Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment;Frontiers in Endocrinology;2019-01-21
5. Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer;Scandinavian Journal of Urology;2016-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3